AbTherx explores Tijuana as a strategic hub for biotechnology investment

AbTherx, a leading biotechnology company specializing in antibody discovery, is exploring the establishment of an administrative hub in Tijuana, Baja California, as part of its strategy to accelerate operations and expand its footprint in North America. The proposed facility would begin with an initial team of ten professionals and serve as a foundation for future growth in the region’s fast-evolving biotech ecosystem.

A gateway for binational innovation

Tijuana’s proximity to San Diego and Silicon Valley, combined with its growing base of specialized talent, research institutions, and support services, has positioned the city as a bridge between Mexico’s industrial capabilities and the United States’ innovation-driven economy. For companies like AbTherx, this unique location offers a cost-efficient, globally connected environment for research, operations, and collaboration.

The meeting between AbTherx representatives and local economic development leaders underscored the advantages that Baja California provides for high-value industries, including competitive costs, access to skilled professionals, and government programs supporting biotech investment. The company’s exploration phase also includes evaluating available incentives and regional programs to facilitate the landing of biotechnology projects in Tijuana.

Advancing biotechnology through partnership and technology

Founded on two decades of scientific expertise, AbTherx is redefining therapeutic antibody discovery through its proprietary Atlas™ Mouse platform, which enables the development of monoclonal and bispecific antibodies targeting complex therapeutic areas such as GPCRs and ion channels. The company’s flexible collaboration models — from standard licensing to customized partnerships — make it an attractive ally for both biotech startups and global pharmaceutical leaders.

AbTherx’s potential arrival in Tijuana would strengthen the region’s position as a binational biotechnology hub, linking Mexico’s competitive manufacturing and operational capabilities with California’s research and innovation ecosystem. This project exemplifies how cross-border collaboration continues to drive the next generation of health and life sciences industries in North America.